A study in healthy volunteers to assess the tolerability and blood levels of a single dose of AZD7687
Study identifier:D2710C00001
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
A randomized, blind, placebo-controlled, single-centre phase I study in healthy volunteers to assess the safety, tolerability and pharmacokinetics of AZD7687 after single ascending oral doses
Medical condition
Healthy
Phase
Phase 1
Healthy volunteers
Yes
Study drug
AZD7687, Placebo
Sex
Male
Actual Enrollment
64
Study type
Interventional
Age
20 Years - 45 Years
Date
Study Start Date: 01 Nov 2009
Primary Completion Date: 01 Jun 2010
Study Completion Date: 01 Jun 2010
Study design
Allocation: Randomized
Endpoint Classification: Safety Study
Intervention Model: Single Group Assignment
Masking: Double Blind
Primary Purpose: Other
Verification:
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| Experimental: Active AZD7687 oral suspension | Drug: AZD7687 Single oral dose |
| Experimental: Placebo placebo oral suspension | Drug: Placebo Single oral dose |
